Impacting the Opioid Crisis: Prevention, Education, and Practice for non-Prescribing Providers


This free course will empower non-prescribing providers and other learners in directly impacting the opioid epidemic through increased knowledge and tools to transform practice and policies.

The course will consider the opioid epidemic from several evidence-based strategies including prevention, intervention, education and policy.

This open learning course is designed primarily for non-prescribing healthcare, behavioral health, dental, public health, and social services professionals, as well as graduate level students in these fields.

As a learner, you will have the ability to select all modules or individual topics that interest you most. The course can be followed in a linear or non-linear structure according to your preferred viewing order.


• Epidemiology of the Opioid Crisis

• Understanding of Pain and Drug Targeting

• Prevention of Misuse and Abuse

• Clinical Care and Population Health

• Addiction Treatment, Recovery and Public Policy Impact


The University of Michigan Medical School designates this enduring material for a maximum of 15 AMA PRA Category 1 Credit(s)™. The University of Michigan Medical School is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

This activity contributes to the CME component of the American Board of Anesthesiology’s redesigned Maintenance of Certification in Anesthesiology™ (MOCA®) program, known as MOCA 2.0®. Please consult the ABA website,, for a list of all MOCA 2.0 requirements.

This course is approved by the Michigan Social Work Continuing Education Collaborative-Approval #101619-02 for 15 CE hours. The Collaborative is the approving body for the Michigan Board of Social Work.

This course is approved by the Michigan Board of Pharmacy-Approval #539190044. This approval statement is for University of Michigan Institute for Healthcare Policy & Innovation. The Michigan Board of Pharmacy designates this enduring material for a maximum of 13 Continuing Education (CE) Hours. Pharmacists should claim only the credit commensurate with the extent of their participation in the activity.